In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

Belief is your safe passage—the door through which all healing resides. Why? Because your perception is your reality. Believing in the science of TMS ( tension myositis syndrome) sends a message of ...

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

Even a myriad of medications — pain relievers and anti-nausea and migraine drugs — haven’t helped the high school senior, who ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

In the future, these findings could also be used to develop novel brain-based treatments and preventatives that reduce the prevalence of chronic pain,” she added. In an accompanying editorial ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

scientists can predict which patients will develop chronic pain based on the extent of cross 'talk' between two regions of the brain, and ... Oct. 22, 2024 — In a study, researchers use ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...